JP2011522893A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011522893A5 JP2011522893A5 JP2011513592A JP2011513592A JP2011522893A5 JP 2011522893 A5 JP2011522893 A5 JP 2011522893A5 JP 2011513592 A JP2011513592 A JP 2011513592A JP 2011513592 A JP2011513592 A JP 2011513592A JP 2011522893 A5 JP2011522893 A5 JP 2011522893A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- composition according
- imidazol
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5983708P | 2008-06-09 | 2008-06-09 | |
| US61/059,837 | 2008-06-09 | ||
| PCT/US2009/046432 WO2009152052A1 (en) | 2008-06-09 | 2009-06-05 | Methods of treating alpha adrenergic mediated conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011522893A JP2011522893A (ja) | 2011-08-04 |
| JP2011522893A5 true JP2011522893A5 (https=) | 2012-07-26 |
| JP5571072B2 JP5571072B2 (ja) | 2014-08-13 |
Family
ID=40823137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011513592A Expired - Fee Related JP5571072B2 (ja) | 2008-06-09 | 2009-06-05 | アルファアドレナリン介在症状の治療方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8071636B2 (https=) |
| EP (3) | EP2303264B1 (https=) |
| JP (1) | JP5571072B2 (https=) |
| CN (1) | CN102099032B (https=) |
| AU (1) | AU2009257692A1 (https=) |
| CA (3) | CA2959793A1 (https=) |
| DK (2) | DK2932968T3 (https=) |
| ES (2) | ES2672777T3 (https=) |
| HU (1) | HUE039357T2 (https=) |
| PL (2) | PL2303264T3 (https=) |
| PT (2) | PT2303264T (https=) |
| SI (1) | SI2303264T1 (https=) |
| TR (1) | TR201802766T4 (https=) |
| WO (1) | WO2009152052A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120083508A1 (en) * | 2006-12-22 | 2012-04-05 | Allergan, Inc. | Alpha-2b receptor agonist and anticonvulsant compositions for treating chronic pain |
| US7902247B2 (en) * | 2008-01-09 | 2011-03-08 | Allergan, Inc. | Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors |
| PL2605771T3 (pl) * | 2010-08-16 | 2018-10-31 | Allergan, Inc. | Sposób aktywacji limfocytów t regulacyjnych za pomocą agonistów receptorów alfa-2b-adrenergicznych |
| JP6756435B2 (ja) * | 2014-03-31 | 2020-09-16 | ザ スクリプス リサーチ インスティテュート | Ｔｒａｉｌ誘導のためのファーマコフォア |
| EP3700536A4 (en) | 2017-10-27 | 2021-11-17 | Shanghai Yao Yuan Biotechnology Co., Ltd. | COMPOSITIONS AND PROCEDURES FOR MODULATING IMMUNE REACTION BY ACTIVATING ALPHA-PROTEIN KINASE 1 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6708160A (https=) * | 1966-06-30 | 1968-01-02 | ||
| DE2259160A1 (de) * | 1972-12-02 | 1974-06-06 | Boehringer Sohn Ingelheim | Neue substituierte 2-phenylaminoimidazoline, deren saeureadditionssalze und verfahren zur herstellung derselben sowie ihre verwendung als arzneimittel |
| US4256755A (en) | 1980-04-28 | 1981-03-17 | E. I. Du Pont De Nemours & Company | Method of using N-substituted dihydro-2-oxazolamines as analgesics |
| FR2806082B1 (fr) * | 2000-03-07 | 2002-05-17 | Adir | Nouveaux composes bicycliques antagonistes des recepteurs de la vitronectine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2002089794A1 (en) * | 2001-05-07 | 2002-11-14 | Universite Catholique De Louvain | Method for treating neuropathic pain and pharmaceutical preparation therefor |
| EP1333028A1 (en) * | 2002-01-31 | 2003-08-06 | Boehringer Ingelheim Pharma GmbH & Co.KG | 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence |
| US7345065B2 (en) | 2002-05-21 | 2008-03-18 | Allergan, Inc. | Methods and compositions for alleviating pain |
| CN101287366A (zh) | 2005-05-19 | 2008-10-15 | 拜尔农作物科学股份公司 | 杀虫的取代的苄基氨基杂环及杂芳基衍生物 |
| WO2008123821A1 (en) * | 2007-03-01 | 2008-10-16 | Albireo Ab | 4, 5-dihydro-lh-imidazol-2-amine derivatives for use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders |
| CN101687812A (zh) * | 2007-07-02 | 2010-03-31 | 弗·哈夫曼-拉罗切有限公司 | 对痕量胺相关受体(taar)具有良好亲和性的2-咪唑啉化合物 |
| WO2009052075A2 (en) * | 2007-10-18 | 2009-04-23 | Allergan, Inc. | Method of treating motor disorders with alpha-2b adrenergic receptor agonists |
-
2009
- 2009-06-05 ES ES09763343.2T patent/ES2672777T3/es active Active
- 2009-06-05 WO PCT/US2009/046432 patent/WO2009152052A1/en not_active Ceased
- 2009-06-05 CN CN200980126849.0A patent/CN102099032B/zh not_active Expired - Fee Related
- 2009-06-05 AU AU2009257692A patent/AU2009257692A1/en not_active Abandoned
- 2009-06-05 SI SI200931858T patent/SI2303264T1/en unknown
- 2009-06-05 PL PL09763343T patent/PL2303264T3/pl unknown
- 2009-06-05 CA CA2959793A patent/CA2959793A1/en not_active Abandoned
- 2009-06-05 US US12/479,129 patent/US8071636B2/en active Active
- 2009-06-05 PL PL15165926T patent/PL2932968T3/pl unknown
- 2009-06-05 JP JP2011513592A patent/JP5571072B2/ja not_active Expired - Fee Related
- 2009-06-05 ES ES15165926.5T patent/ES2665293T3/es active Active
- 2009-06-05 TR TR2018/02766T patent/TR201802766T4/tr unknown
- 2009-06-05 EP EP09763343.2A patent/EP2303264B1/en active Active
- 2009-06-05 EP EP15165926.5A patent/EP2932968B1/en active Active
- 2009-06-05 DK DK15165926.5T patent/DK2932968T3/en active
- 2009-06-05 EP EP11174152A patent/EP2377534A1/en not_active Withdrawn
- 2009-06-05 HU HUE09763343A patent/HUE039357T2/hu unknown
- 2009-06-05 PT PT97633432T patent/PT2303264T/pt unknown
- 2009-06-05 PT PT151659265T patent/PT2932968T/pt unknown
- 2009-06-05 CA CA2744929A patent/CA2744929C/en active Active
- 2009-06-05 CA CA3133261A patent/CA3133261A1/en not_active Abandoned
- 2009-06-05 DK DK09763343.2T patent/DK2303264T3/en active
-
2011
- 2011-10-17 US US13/274,471 patent/US20120035235A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011522893A5 (https=) | ||
| AU2004242967C1 (en) | Compounds, formulations, and methods for treating or preventing rosacea | |
| RU2018128318A (ru) | Селективные ингибиторы эстрогеновых рецепторов и их применение | |
| JP2011057693A5 (https=) | ||
| JP2013545730A5 (https=) | ||
| JP2014508752A5 (https=) | ||
| EP2786985A3 (en) | Antagonists of the glucagon receptor | |
| JP2006510716A5 (https=) | ||
| JP2011042668A5 (https=) | ||
| JP2017524005A5 (https=) | ||
| JP2015534577A5 (https=) | ||
| JP2015524472A5 (https=) | ||
| JP2010525056A5 (https=) | ||
| JP2008500356A5 (https=) | ||
| RU2017116197A (ru) | 2-амино-3,5-дифтор-3,6-диметил-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 для лечения болезни альцгеймера | |
| JP2012111764A5 (https=) | ||
| HRP20170502T1 (hr) | Antagonisti cb 1 receptora | |
| RU2009103675A (ru) | Производные бензимидазола в лечении расстройств, ассоциированных с ванилоидным рецептором trpv1 | |
| JP2017508782A5 (https=) | ||
| ES2670686T3 (es) | Compuestos que tienen actividad antagonista del receptor muscarínico y agonista del receptor beta2 adrenérgico | |
| JP2023116697A5 (https=) | ||
| JP2014510782A5 (https=) | ||
| RU2017120217A (ru) | 2-амино-5,5-дифтор-6-(фторметил)-6-фенил-3,4,5,6-тетрагидпропиридины в качестве ингибиторов bace1 | |
| JP2013500977A5 (https=) | ||
| CA2628844A1 (en) | Pyrazole derivatives and their medical use |